Share Prices & Company Research

Stockbroking

Genomic Vision

Current Price 83.82p Bid 2.67p Ask 1.54p Change 0.00%
Last Updated: 15/06/2025 11:16. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Financial Highlights Year Ended 31/03/2020

Revenue
£n/am
Operating Profit/Loss
£1.36m
Dividend yield (%)
1.20
Total dividend for year
1.0000p
Dividend cover
1.09
P/E Ratio
75.70

Stock Details

EPIC
GVP
ISIN
FR0011799907
Shares in Issue
0.00m
Market cap
£0.00m

Analyst Views (0)

Strong Buy
 
0%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
83.82p
Bid Price
2.67p
Ask Price
1.54p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
83.82p
Previous Close
83.82p
Intraday High
83.82p
Intraday Low
83.82p
52 Week High
83.82p
52 Week Low
83.82p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

News

Income Statement

Year End Date
31 Mar 2020
31 Mar 2019
 
£ (M)
£ (M)
Continuing Operations
Revenue
n/a
n/a
Operating Profit/Loss
1.36
1.02
Net Interest
n/a
n/a
Pre-Tax Profit
1.36
1.02
Profit After Tax from continuing operations
1.08
0.76
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
n/a
n/a
Attributable to:
Equity Holders of Parent Company
n/a
n/a
Minority Interests
n/a
n/a
Total Dividend Paid
1.0000p
0.7500p
Retained Profit/(Loss) for the Financial Year
1.08
0.76

Earnings per Share

Year End Date
31 Mar 2020
31 Mar 2019
Basic
1.09p
0.76p
Diluted
1.09p
0.76p
Adjusted
1.09p
0.76p
Dividend per Share
1.0000p
0.7500p

Assets

Year End Date
31 Mar 2020
31 Mar 2019
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
n/a
n/a
Intangible Assets
n/a
n/a
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
n/a
n/a
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
n/a
n/a
Cash at Bank & In Hand
12.37
0.79
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
102.50
138.40

Liabilities

Year End Date
31 Mar 2020
31 Mar 2019
 
£ (M)
£ (M)
Current Liabilities
Borrowings
n/a
n/a
Other Current Liabilities
n/a
n/a
Total Current Liabilities
n/a
n/a
Non-Current Liabilities
Borrowings
n/a
n/a
Provisions
n/a
n/a
Other Non-Current Liabilities
n/a
n/a
Total Non-Current Liabilities
n/a
n/a
Other Liabilities
n/a
n/a
Total Liabilities
1.23
0.88

Net Assets

Year End Date
31 Mar 2020
31 Mar 2019
 
£ (M)
£ (M)
Net Assets
101.27
137.52

Capital & Reserves

Year End Date
31 Mar 2020
31 Mar 2019
 
£ (M)
£ (M)
Share Capital
n/a
n/a
Share Premium Account
n/a
n/a
Other Reserves
98.99
135.58
Retained Earnings
n/a
n/a
Shareholders Funds
101.27
137.52
Minority Interests/Other Equity
n/a
n/a
Total Equity
n/a
n/a

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Interim
17 Jun 2021
02 Jul 2021
0.20p
2nd Interim
17 Jun 2021
02 Jul 2021
1.20p
Interim
28 Jan 2021
19 Feb 2021
0.10p
Final
16 Jul 2020
14 Aug 2020
1.00p
Final
04 Jul 2019
09 Aug 2019
0.75p
Final
28 Jun 2018
21 Aug 2018
0.60p
Final
29 Jun 2017
24 Jul 2017
1.20p
Final
30 Jun 2016
25 Jul 2016
0.30p

Dividend Metrics

Year End Date
31 Mar 2020
31 Mar 2019
Dividend growth
33.33%
25.00%
Dividend yield
1.20%
0.60%
Dividend cover
1.09
1.01


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.